文献速递妇科产科

宫颈上皮内瘤变3级中非筛查型HPV基因型的年龄相关分布

Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3.
PubMed 文献 · Gynecol Oncol · 2021-03-29

回顾性多中心研究纳入2014–2019年锥切组织学确诊CIN3且HPV基因分型的1332例未接种疫苗女性,按年龄<30、30–44、≥45岁分组,分析非筛查型HPV及非HPV-16/18的分布。结果显示非筛查型HPV CIN3占5.5%,非HPV-16/18占31.3%;≥45岁女性非筛查型HPV风险升高(OR=1.87,95%CI 1.07–3.25,p=0.027),且非筛查型HPV及非HPV-16/18比例均随年龄显著增加。结论提示年龄可能修饰HPV型别相关CIN3风险,风险推荐应纳入年龄。

要点

  • ≥45岁女性非筛查型HPV相关CIN3风险升高(OR=1.87,95%CI 1.07–3.25,p=0.027)。
  • 非筛查型HPV患病率随年龄显著增加(3.9% vs 5.1% vs 9.0%,p=0.016)。
  • 非HPV-16/18 CIN3比例随年龄呈正趋势(23.6% vs 32.1% vs 38.0%,p=0.0004)。

核心结论

  • CIN3病变中由初级筛查未检测基因型所致的比例随年龄增加,年龄可能修饰HPV型别相关CIN3及癌变风险。
  • 基于风险的推荐应考虑年龄以定义HPV阳性女性的管理。

研究设计与样本

  • 回顾性多中心研究,纳入2014–2019年锥切组织学确诊CIN3且HPV基因分型的未接种疫苗女性1332例。
  • 按年龄分为<30、30–44、≥45岁三组,HPV基因型分为非筛查型HPV(不含16/18/31/33/35/39/45/51/52/56/58/59/66/68)和非HPV-16/18。
  • 测量不同年龄组与HPV基因型之间的关联及趋势。

主要发现

  • 非筛查型HPV CIN3共73例(5.5%),非HPV-16/18共417例(31.3%)。
  • ≥45岁女性与非筛查型HPV相关(OR=1.87,95%CI 1.07–3.25,p=0.027)。
  • 非筛查型HPV患病率随年龄显著增加(3.9% vs 5.1% vs 9.0%,p=0.016)。
  • <30岁女性非HPV-16/18比例较低(OR=0.65,95%CI 0.47–0.89,p=0.007)。
  • 非HPV-16/18 CIN3随年龄呈正趋势(23.6% vs 32.1% vs 38.0%,p=0.0004)。

关键数值与推荐

  • 非筛查型HPV定义为不含基因型16/18/31/33/35/39/45/51/52/56/58/59/66/68。
  • 非筛查型HPV CIN3占5.5%(73/1332),非HPV-16/18占31.3%(417/1332)。
  • ≥45岁女性非筛查型HPV的OR=1.87(95%CI 1.07–3.25,p=0.027)。
  • 非筛查型HPV患病率按<30、30–44、≥45岁分别为3.9%、5.1%、9.0%(p=0.016)。
  • 非HPV-16/18 CIN3比例按<30、30–44、≥45岁分别为23.6%、32.1%、38.0%(p=0.0004)。

临床怎么用

  • 在宫颈癌筛查风险评估中应考虑年龄对HPV型别相关CIN3风险的影响。
  • 对≥45岁HPV阳性女性,需关注非筛查型HPV及非HPV-16/18所致CIN3的风险。
  • 基于风险的推荐应结合年龄制定HPV阳性女性的管理策略。

局限性

  • 回顾性多中心研究设计可能存在选择偏倚。
  • 样本限于未接种疫苗且锥切组织学确诊CIN3的女性,外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Cervical cancer prevention guidelines include Human Papillomavirus (HPV) test, cytology, and HPV-16/18 typing for triage to determine the risk of cervical intraepithelial neoplasia (CIN) grade 3 as the best proxy of cervical cancer risk. In doing that, they do not consider how age can modify the type-specific risk of CIN3. The present study aimed to evaluate the age-related distribution of HPV genotypes affecting the risk-assessment in cervical cancer screening programs: non-screening-type-HPV and non-HPV-16/18 in unvaccinated women with CIN3. METHODS: Retrospective multi-institutional study, including HPV genotyped women with CIN3 on cone histology treated between 2014 and 2019. The sample was divided into three categories of age: <30, 30-44, ≥45. HPV genotypes were grouped in non-screening-type-HPV (not-including genotypes 16/18/31/33/35/39/45/51/52/56/58/59/66/68) and non-HPV-16/18. Associations and trends between different age-groups and HPV genotypes were measured. RESULTS: 1332 women were analyzed. Non-screening-type-HPV CIN3 were 73 (5.5%). Non-HPV-16/18 were found in 417 participants (31.3%). Women over 45 associated with non-screening-type HPV [odds ratio (OR) = 1.87, 95% confidence interval (CI) 1.07-3.25; p = 0.027]. Non-screening-type-HPV prevalence increased significantly with age (3.9% vs 5.1% vs 9.0%, p = 0.016). Women under 30 showed a lower rate of non-HPV-16/18 (OR = 0.65, 95% CI 0.47-0.89; p = 0.007). There was a positive trend with age of non-HPV-16/18 CIN3 (23.6% vs 32.1% vs 38.0%, p = 0.0004). CONCLUSION: The proportion of CIN3 lesions unrelated to genotypes detected by primary screening tests increased with age. This implies that age probably modifies the risk of CIN3 and possibly of cancer associated with HPV types. The risk-based recommendation should take into consideration age to define the management of HPV positive women.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Giannella L, Giorgi Rossi P, Delli Carpini G, et al. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3. Gynecol Oncol. 2021. PMID: 33795132. doi:10.1016/j.ygyno.2021.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。